Menu
Contact Us
Subscribe
Menu

European Union

Articles on this Topic

Other Topics

Recent Articles

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

Ellen 't Hoen -
This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year – expanding access and prolonging lives

Kaitlin Mara -
Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope...

WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument

Ellen 't Hoen -
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and...

FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV

Ellen 't Hoen -
On 18th June 2025, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of...
Load more

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's newsletter.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.